Every Form 4 that Life360, Inc. (LIF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LIF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LIF filings page.
Life360, Inc. director Synge James reported a bona fide gift of 8,333 shares of common stock on March 17, 2026. The transfer was made for charitable purposes and involved no sale proceeds. After this gift, James holds 186,421 shares of common stock, including shares underlying Chess Depositary Interests and 703 restricted stock units.
Life360, Inc. director David Wiadrowski reported an option exercise and related share sale. On March 13, 2026, he exercised stock options for 21,310 shares of common stock, including 13,850 shares at an exercise price of $13.35 and 7,460 shares at $8.19 per share.
The filing shows an open-market sale of 5,957 shares of common stock at a weighted average price of $41.34 per share, with footnotes stating these shares were sold solely to cover the option exercise cost. After these transactions, he directly owned 39,679 shares of common stock, which includes 738 restricted stock units that will convert into shares upon vesting.
Life360, Inc. director Charles J. Prober reported an exercise-and-sell transaction involving 7,930 shares. On 2026-03-13, he exercised stock options to acquire 7,930 shares of common stock at an exercise price of $11.18 per share, then sold 7,930 shares of common stock at $41.40 per share in an open-market transaction.
The activity was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-03-14. After these transactions, Prober directly held 105,456 shares of common stock, including 679 restricted stock units that each represent a right to receive one share upon vesting.
Life360 director John Philip Coghlan, through the John Coghlan Living Trust, reported open-market sales of 4,000 shares of common stock on March 9, 2026. The shares were sold in two trades at weighted average prices of $45.29 and $46.56 per share.
The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, meaning they were scheduled in advance. After these transactions, the trust held 5,065 shares, while Coghlan also held 36,202 shares directly and 55,494 shares indirectly through a separate grantor retained annuity trust, including 836 restricted stock units.
Life360, Inc. Chief Financial Officer Russell John Burke reported a routine equity compensation event. On the vesting and net settlement of previously granted restricted stock units, 5,800 shares of common stock were withheld by the company to satisfy income tax withholding and remittance obligations, and this is explicitly not a sale by the executive.
Following this tax-withholding disposition, Burke holds 78,857 shares of common stock directly and 91,077 shares indirectly through the Russell John Burke Revocable Trust. These indirect holdings include 56,573 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting.
Life360, Inc. director Chris Hulls reported a routine tax-related share disposition. On March 6, 2026, 5,248 shares of common stock were withheld by the company at $44.91 per share to satisfy income tax obligations tied to vesting restricted stock units, and were not sold in the open market. After this withholding, Hulls held 322,452 shares directly, a figure that includes common stock, shares underlying Chess Depositary Interests, and 108,371 unvested restricted stock units. The filing also shows indirect holdings of 195,312 shares each in three separate 2023 irrevocable trusts.
Life360, Inc. Chief Executive Officer Lauren Antonoff sold 17,153 shares of common stock at $44.86 per share. According to the disclosure, this was a sell-to-cover transaction to satisfy tax withholding obligations from vesting RSUs, not a discretionary sale. After the sale, Antonoff directly held 288,232 shares and had 143,367 RSUs outstanding.
Life360, Inc. director John Philip Coghlan exercised a stock option and acquired 31,938 shares of common stock at $0.18 per share through a derivative exercise on March 5, 2026. After this transaction, he directly holds 36,202 shares of common stock, which includes 1,672 restricted stock units that each represent a contingent right to receive one share upon vesting.
He also has indirect ownership of common stock, with 9,065 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. The reported numbers were adjusted because a previously reported transfer of 1,672 directly held shares to the living trust has not yet occurred.
Life360, Inc. director Charles J. Prober exercised stock options for 7,930 shares of common stock at an exercise price of $11.18 per share on February 13, 2026, then sold 7,930 shares in open-market transactions at an average price of $49.02 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025. Following these transactions, he directly holds 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and retains 71,370 stock options subject to the vesting schedule described.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and updated share holdings. On 01/14/2026, he exercised a stock option to acquire 12,427 shares of common stock at $3.58 per share, bringing his directly held common stock (including awards) to 84,657 shares. This direct position includes 72,230 restricted stock units, each representing a contingent right to one share upon vesting. He also reports 91,077 common shares held indirectly by the Russell John Burke Revocable Trust following a transfer of 18,524 directly held shares that was exempt from Section 16 under Rule 16a-13. After the transaction, a fully vested and exercisable stock option covering 419,087 shares of common stock remains outstanding.
Life360, Inc. director Charles J. Prober reported an option exercise and share sale in the company’s stock. On January 13, 2026, he exercised a stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, then sold the same 7,930 shares at a price of $61.98 per share. After these transactions, he directly owned 105,456 shares of common stock, which includes 1,357 restricted stock units that can convert into shares upon vesting, and held 79,300 stock options outstanding.
The filing notes that the transaction was carried out under a Rule 10b5‑1 trading plan adopted on March 14, 2025. This plan is a pre-arranged, automatic trading program that was put in place when the director stated they were not aware of any material nonpublic information about Life360.
Life360, Inc. director reported an insider transaction involving stock options and common shares. On 12/15/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share, then sold 7,930 shares of common stock at $68.3 per share under transaction codes M and S.
After these transactions, the director beneficially owned 105,456 shares of common stock, including 1,357 restricted stock units that each convert into one share upon vesting, and held 87,230 stock options at an exercise price of $11.18 per share. The filing states the trades were made under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, and also corrects previously misreported vesting terms for the stock option.
Life360, Inc. Chief Financial Officer Russell John Burke reported an option exercise and related share holdings update. On 12/15/2025, he exercised a stock option to buy 2,500 shares of Life360 common stock at an exercise price of $3.58 per share, classified as transaction code "M". Following this transaction, he beneficially owned 90,754 shares directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust.
The directly held amount includes 72,230 restricted stock units, each representing a contingent right to receive one share of common stock upon vesting. After the exercise, Burke also held 431,514 stock options directly, and the reported option is noted as fully vested and exercisable with an expiration date of 05/19/2030.
Life360, Inc. director John Coghlan reported an insider transaction involving stock options and common stock. On 12/12/2025, he acquired 920 shares of common stock through the exercise of a stock option with an exercise price of $2.15, reflected with transaction code "M".
After the transaction, he beneficially owns 2,592 shares directly, plus 10,737 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. His derivative holdings include 142,306 stock options. The footnotes state that 1,672 directly held shares were transferred to the John Coghlan Living Trust under an exemption, that 2,592 direct holdings include 1,672 restricted stock units, and that the reported stock option is fully vested and exercisable.
Life360, Inc. director John Coghlan reported sales, transfers and a charitable gift of company common stock. On 12/05/2025, the John Coghlan Living Trust sold 2,025 shares at a weighted average price of $76.82 and 1,100 shares at a weighted average price of $77.96, in each case under a Rule 10b5-1 trading plan adopted on December 6, 2024.
On 12/09/2025, he made a bona fide gift of 3,045 shares to a donor-advised fund for charitable purposes and transferred 3,045 shares between the John Coghlan Living Trust and The John Philip Coghlan 2025 Grantor Retained Annuity Trust in transactions described as exempt under Rule 16a-13.
Following these transactions, he beneficially owns 3,344 shares directly, 9,065 shares through the John Coghlan Living Trust and 55,494 shares through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, including 1,672 restricted stock units that each represent one share upon vesting.
Life360, Inc.'s Chief Financial Officer reported a tax-related share withholding. On 12/04/2025, the issuer withheld 9,978 shares of common stock at $75.02 per share to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously granted restricted stock units, rather than an open-market sale.
After this transaction, the officer beneficially owned 88,254 shares of Life360 common stock directly and 72,553 shares indirectly through the Russell John Burke Revocable Trust. These holdings also include 72,230 restricted stock units previously granted, each representing a contingent right to receive one share of common stock upon vesting.
Life360, Inc. reported that one of its directors sold common stock in the company. On 12/03/2025, the director sold 15,000 shares of Life360 common stock at a weighted average price of $74.19 per share, with individual trade prices ranging from $74.13 to $74.46. After this transaction, the director beneficially owns 56,809 shares indirectly through the Goines Wong Living Trust and 6,070 shares directly. The direct holdings include 2,339 restricted stock units, each representing the right to receive one share of common stock upon vesting.
Life360, Inc. (LIF) CEO and director reports a small stock sale under a preset trading plan. On 11/24/2025, the reporting person sold 4,546 shares of Life360 common stock at a price of $76.1 per share, coded as an "S" transaction. This sale was made pursuant to a Rule 10b5-1 trading plan adopted on November 27, 2024, which provides for automatic sales based on predetermined criteria and was put in place when the insider was not aware of material nonpublic information.
After this transaction, the insider beneficially owns 324,827 shares of Life360 common stock, including 222,277 restricted stock units that each represent a contingent right to receive one share upon vesting.
Life360, Inc. (LIF) Chief Financial Officer updates holdings and corrects prior option terms. The reporting person exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share. After the transaction, the reporting person directly held 98,232 common shares and indirectly held 72,553 shares through the Russell John Burke Revocable Trust.
The filing notes that 9,523 directly held shares were previously transferred to the revocable trust under an exemption from Section 16. It also states that 91,732 restricted stock units are included in the beneficial ownership total, each representing a right to receive one common share upon vesting. The stock option underlying this exercise is now fully vested and exercisable, and the vesting terms previously reported for this option were inadvertently misreported and are corrected in this filing.
Life360, Inc. (LIF) reported that one of its directors exercised and sold shares under a pre-arranged trading plan. On 11/13/2025, the director exercised a stock option to acquire 7,930 shares of common stock at $11.18 per share and, on the same date, sold 7,930 shares of common stock at $76.93 per share. After these transactions, the director beneficially owned 105,456 shares of common stock, including 2,036 restricted stock units, and held 95,160 stock options. The filing notes that these trades were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, and it corrects the vesting commencement date of the reported stock option to April 1, 2024.
Life360, Inc. (LIF) director John P. Coghlan reported open‑market sales on 11/03/2025 made under a Rule 10b5‑1 trading plan adopted on December 6, 2024. The transactions included 2,866 shares at a weighted average price of $98.88 and 259 shares at a weighted average price of $99.47.
Following the transactions, beneficial ownership reported included 15,235 shares held by the John Coghlan Living Trust, 3,344 shares held directly, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. Holdings include 2,508 restricted stock units. The filing also notes an exempt transfer of 12,110 shares from the GRAT to the Living Trust pursuant to Rule 16a‑13.